contact[at]op2lysis.com

The company
The Technology
Products
Indications
News
Contact

Search for:

Orphan drug designation granted to OptPA for the treatment of non-traumatic spontaneous intracerebral hemorrhage by the European Commission

Home
Corporate
Orphan drug designation granted to OptPA for the treatment of non-traumatic spontaneous intracerebral hemorrhage by the European Commission

ODD-EMA Télécharger

Biotechnology company that researches and develops innovative medicines

Supported by

SItemap

Contact
home
Indications
Legal Notice
News
Products
The company
The Technology

Recent Posts

Nominated for the GALIEN USA 2023 award “Best Startup”

October 12, 2023

Funding for the ThromboSTROKE collaborative research project

October 15, 2024

Sucessful DRF toxicology Study

September 03, 2024

Contact

FRANCE: 117 avenue Victor Hugo, 92100 Boulogne-Billancourt, France BELGIUM: Légia Park, Boulevard Patience et Beaujonc, 3, 4000 Liège, Belgium

Op2Lysis © 2022 All Rights Reserved – Legal notice – web agency : Bridge Communication